These results indicate that both aging and Alzheimer’s disease-like pathology increase susceptibility to post-anesthesia cognitive impairment, and that intranasal insulin treatment may protect against anesthesia-induced cognitive decline. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.